PROSCA & BLADDR 2022
R

Radical Cystectomy With Ileal Conduit: Lessons to Be Learned

By PROSCA & BLADDR 2022 FEATURING Richard Meijer
By PROSCA & BLADDR 2022 FEATURING Richard Meijer
57 views
December 28, 2022
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
International Urology Cancer Summit - IUCS

Second International Urology Cancer Summit

Fri, Sep 27, 2024
16:05
Insights from 2024 ASCO® GU Annual Meeting

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini
09:55
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future H…

Feat. E. Hamilton
20:41
2024 ASCO® Annual Meeting Insights Hub

Bladder Cancer Highlights From ASCO® 2024

Feat. G. Sonpavde
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
29:25
Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae
21:08
Integrity CE

Updates in the Treatment and Management of Bladder Cancer

Feat. M. Galsky, B. Guercio
22:19
Insights from 2023 ESMO Annual Meeting

Bladder Cancer Highlights From ESMO 2023: Comparing and Contrasting …

Feat. G. Sonpavde
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
22:07
Weill Cornell Medicine Oncology & Hematology

Urothelial Carcinoma: New Developments

Feat. C. Sternberg
17:32
Kriti Mittal

Current Updates in Urothelial Cancer: Clinical Implications for Prac…

14:00
Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Summary: "Key Highlights in Bladder/Urothelial Ca…

Feat. G. Sonpavde
15:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Bladder and RCC Highlights"

Feat. K. Tawagi, N. Reizine
06:01
ecancer

ESMO 2023 Insights: "Phase 3 EV-302 Trial - Evaluating the Comb…

Feat. T. Powles
30:03
UCSF School of Medicine

Recent Advances in Advanced Urothelial Cancers: Time for a New Stand…

Feat. T. Friedlander
13:54
AdventHealth

FDA Approval of Gemcitabine-Cisplatin + Nivo as 1L Therapy for Advan…

Feat. G. Sonpavde
04:16
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "KEYNOTE-361 Trial - Quantitative ctDNA As…

Feat. T. Powles
17:03
Total Health

Emerging Trends in Localized Bladder Cancer in 2024

Feat. N. Gopal
25:32
Memorial Sloan Kettering Cancer Center

Multidisciplinary Approaches for Muscle Invasive Bladder Cancer

Feat. B. Bochner
20:20
Miami Cancer Institute Precision Oncology Symposium

The Role of Biomarkers in Urothelial Carcinoma: Current Status and F…

Feat. S. Gupta
09:12
AdventHealth

Update on the FDA Accelerated Approval of Enfortumab Vedotin + Pembr…

Feat. G. Sonpavde